Stallion India Fluorochemicals Limited has informed the Exchange about General Updates
STALLION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Stallion India Fluorochemicals' Board has approved a new Employee Stock Option Plan called 'ESOP 2025' on August 8, 2025, subject to shareholder approval at the upcoming Annual General Meeting. The plan allows for the grant of up to 31,73,010 equity shares (face value Rs. 10 each) to eligible employees, including directors (excluding independent directors and promoters). Options will vest over a period of 1 to 5 years from the grant date and can be exercised within 4 years of vesting, with no lock-in period on shares issued upon exercise. The exercise price will be set by the Nomination and Remuneration Committee, between the face value and the prevailing market price.
If approved, ESOP 2025 could result in dilution of existing shareholders' equity by up to ~31.73 lakh shares. The scheme may help attract and retain talent, but the size of the pool and future grants will influence the dilution impact. No immediate price impact is expected since shareholder approval is pending.